Mather Group’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
FLAM
TCM
BCM
SI
Mather Group's ANAB Position: Q1 2025 in Review
Mather Group sold out of AnaptysBio (ANAB) in Q1 2025, closing a stake of 130 shares — an estimated $1.72K sold.
Mather Group first reported a position in ANAB in Q1 2024 and held it in 4 quarters. The position peaked at $4.36K in Q3 2024. 153 funds tracked by Wall St. Rank hold ANAB as of Q1 2025.
- Mather Group reported no remaining AnaptysBio position as of Q1 2025 after selling out during the quarter.
- Mather Group sold 130 AnaptysBio shares in Q1 2025, an estimated $1.72K.
- Mather Group first reported a position in AnaptysBio in Q1 2024 and held it in 4 quarters.
- Mather Group's AnaptysBio position peaked at $4.36K in Q3 2024.
- 153 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2025.
Based on Mather Group's 13F filing for Q1 2025, filed 25 Apr 2025.